Sage’s Big Fat Binary Event is Coming Up
Research - Originally sent to PropThink members on May 3, 2017. Selecta Biosciences (SELB) has been weak since our suggestion two weeks ago, but we still like … Continue Reading
PremiumMust Read
Obesity & PD-1: History Doesn’t Repeat But It Rhymes
The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical Submits 510(k) for Insulin Patch Pump
Modular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLatest Posts
Video: Our April Strategy Webinar is Live
Education - A recording of last night’s webinar is now available! As usual, follow-up questions can be directed to editor@propthink.com. Register And Watch The Video Timestamps below. … Continue Reading
Premium
Learning From Savient’s Mess
Research - Many investors will be familiar with the failed commercial efforts at, and subsequent bankruptcy of, Savient Pharmaceuticals (SVNT). It was a spectacle almost a decade … Continue Reading
Premium
On Paratek’s Broad-Spectrum Pneumonia Win
Research - We’ve discussed Paratek Pharmaceuticals (PRTK) in a few recent webinars, and wanted to follow up in the wake of quality CABP data for omadacycline IV-to-Oral. … Continue Reading
Premium
Investors Size Up New Prescription Drug Bill
Research - Biotech stocks are rolling over a little, possibly due to the release of Senator Al Franken and Democrats’ proposed bill to curb drug prices in … Continue Reading
Read now
Prepare for Upcoming Events With This Webinar
Research - Our March webinar focused primarily on recent events in the bio/pharma space; some actionable ideas for the next few weeks; and of course, politics (AHCA vote … Continue Reading
Read now
Profits From One, Adding To Another
Research - Note – Jake here. I’m just resurfacing after the birth of our second child early this week. Sorry for the delay in returning emails, and … Continue Reading
Premium